Hartford Healthcare R4 (HGHSX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

49.28

-0.45 (-0.90%)

At close: Aug 26, 2026

32.72% (1Y)

Fund Assets	772.21M
Expense Ratio	1.35%
Min. Investment	$0.00
Turnover	40.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 11, 2025

Previous Close	49.73
YTD Return	12.74%
1-Year Return	37.03%
5-Year Return	17.71%
52-Week Low	37.41
52-Week High	49.96
Beta (5Y)	0.84
Holdings	84
Inception Date	Dec 22, 2006

About HGHSX

The Hartford Mutual Funds, Inc.: Hartford Healthcare Fund; Class R4 Shares is an open-end mutual fund that targets long-term capital appreciation by investing primarily in the global health care sector. Its strategy is to allocate at least 80% of assets to equity securities of companies connected to health care industries, including pharmaceuticals, biotechnology, medical products, services, and health care delivery. The fund is sub-advised by Wellington Management Company LLP, leveraging in-depth research to identify high-conviction investment opportunities and capitalize on demographic shifts, globalization, and innovation trends within the health care market. It typically holds 85–100 securities and focuses heavily on U.S.-based firms, with a modest allocation to foreign equities. The R4 share class is designed to be accessible, featuring no minimum investment requirement for standard taxable accounts and an expense ratio around 1.3%. Notable for its annual dividend distribution and a competitive yield, the fund provides investors with targeted exposure to a vital and evolving sector that is integral to global economies and public well-being.

Fund Family Hartford Mutual Funds

Category Health

Performance Rating Average

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol HGHSX

Share Class Class R4

Index S&P Composite 1500 Health Care TR

Performance

HGHSX had a total return of 37.03% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.98%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
HGHVX	Class R6	0.94%
HGHFX	Class F	0.94%
HGHIX	Class I	1.05%
HGHYX	Class Y	1.05%

Top 10 Holdings

47.85% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.39%
Johnson & Johnson	JNJ	6.59%
Merck & Co., Inc.	MRK	6.55%
UnitedHealth Group Incorporated	UNH	4.68%
AbbVie Inc.	ABBV	3.42%
Intuitive Surgical, Inc.	ISRG	2.98%
Elevance Health, Inc.	ELV	2.94%
CVS Health Corporation	CVS	2.92%
Vertex Pharmaceuticals Incorporated	VRTX	2.71%
Danaher Corporation	DHR	2.66%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 11, 2025	$1.40315	Dec 12, 2025
Dec 11, 2024	$1.89862	Dec 12, 2024
Dec 12, 2022	$0.36137	Dec 13, 2022
Dec 10, 2021	$4.37361	Dec 13, 2021
Dec 10, 2020	$5.16605	Dec 11, 2020
Dec 10, 2019	$2.36232	Dec 11, 2019

Full Dividend History